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Tygerberg Academic Hospital is the referral centre for all major burn wounds in adult 
patients in the Western Cape. Patients who underwent surgery for burns related 
injuries at Tygerberg Academic Hospital were identified as having a high incidence of 
moderate to severe postoperative pain in an audit done in 2012 when there was no 
fixed protocol for postoperative analgesia.1 
In an attempt to reduce the incidence of moderate to severe postoperative pain, the 
Department of Anaesthesiology and Critical Care at Tygerberg Academic Hospital 
introduced a new postoperative analgesia protocol in the burns unit in November 
2016. This is, according to our knowledge, the first unit in Tygerberg Academic 
Hospital where pain scores were introduced as part of routine vitals. 
Methods 
A five month interval after the introduction of the new protocol was allowed before an 
audit of patients’ pain experience was commenced. A sample of 64 patients that 
underwent burns related surgery was evaluated. Patients were asked to indicate on 
a printed visual analogue scale (VAS) the worst pain experienced in the first 24 
hours postoperatively, as well as the amount of pain experienced at the time of the 
interview at 24 hours postoperatively. 
These values were compared to the data collected during the audit of 2012 to 
establish whether any improvement had been made. We considered a reduction in 
median VAS score of at least 18mm to be significant. 
Results 
In this study we could not prove a statistically significant difference between the 
control group of Murray and Retief from 2012 and the post-intervention group of 







Tygerberg Akademiese Hospitaal is die verwysingsentrum vir alle ernstige 
brandwonde van volwasse pasiënte in die Wes Kaap. Pasiënte wat chirurgie vir 
brandwondverwante beserings gehad het was geïdentifiseer om ‘n hoë insidensie 
van matig tot ernstige postoperatiewe pyn te hê in ‘n oudit wat gedoen was in 2012.1 
Daar was op daardie stadium geen vasgestelde protokol vir postoperatiewe 
pynverligting nie. 
 
In ‘n poging om die insidensie van matig tot ernstige postoperatiewe pyn te verlaag, 
het die Departement van Anestesiologie en Kritieke Sorg in November 2016 ‘n nuwe 
protokol vir postoperatiewe pynverligting geloods in Tygerberg Akademiese 
Hospitaal se brandwonde eenheid. Hierdie is, sover ons kennis strek, die eerste 
eenheid in Tygerberg Akademiese Hospitaal waar pyntellings as deel van roetine 
observasies begin is. 
 
Metodes 
‘n Vyf maande interval was toegelaat na die bekendstelling van die nuwe protokol 
voor ‘n oudit van pasiënte se pynervaring begin is. ‘n Steekproef van 64 pasiënte wat 
brandwondverwante chirurgie ondergaan het is geëvalueer. Pasiënte het op ‘n 
uitgedrukte Visuele Analoog Skaal (VAS) die ergste pyn ondervind in die eerste 24 
uur na chirurgie, asook die pyn ervaar ten tye van die onderhoud teen 24 uur na 
chirurgie aangedui. 
 
Hierdie waardes is vergelyk met die waardes verkry tydens die vorige oudit in 2012 
om te bepaal of enige verbetering plaasgevind het. Ons het ‘n verlaging in die 
mediaan VAS telling van ten minste 18mm aanvaar as noemenswaardig. 
 
Uitslae 
Ons was nie daartoe in staat om ‘n statisties noemenswaardige verskil tussen die 
kontrole groep van Murray en Retief van 2012 en die post-ingreepgroep van 2017 te 
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The null hypothesis states that there is no difference in the postoperative pain 
experience of patients after the implementation of a comprehensive analgesic 
management plan in patients that had debridement or skin grafting after a burns 
injury. 
 
The alternative hypothesis is that there is a significant difference in the experience of 
postoperative pain in burns patients following debridement or skin grafting between 
the post-interventional group and the control group. 
 
1.2 Aim of the Investigation 
 
Tygerberg Academic Hospital is the referral centre for all adult burns patients in the 
Western Cape. The burns unit is a busy specialist unit with 16 ward beds as well as 
a 6 bed ICU with ventilators. An audit of all elective post-operative patients in 
Tygerberg Academic Hospital by Murray and Retief in 2012 revealed that the 
patients of the burns unit had a high incidence of moderate to severe pain.1 
 
Members of the Department of Anaesthesiology and Critical Care at Stellenbosch 
University developed a new protocol for post-operative pain relief for the burns unit 
of Tygerberg Academic Hospital which was implemented in November 2016. 
 
Nursing staff of different shifts were educated about the new protocol. The practical 
application of the new protocol was explained to them and there were opportunities 
for questions to be asked. The unit manager was present in most of these 
discussions. All the stationery that were to be used were available and explained to 
the staff. Nursing staff members participated very well during the contact sessions. 
Many questions were answered and uncertainties explained. Education regarding 
the specific drugs to be used and their possible benefits were given. The concept of 





Nursing staff had been very excited about the new protocol. They were particularly 
impressed with the introduction of ketamine as a rescue analgesic because they 
were apprehensive of giving morphine too frequently in fear of promoting tolerance 
and addiction in patients.  
 
The aim of this study was to determine whether any progress had been made in 
terms of the severity of postoperative pain experienced by patients in the burns unit 
of Tygerberg Academic Hospital since the previous audit done in 2012.  
 
The primary objective was to measure the severity of postoperative pain and the 
incidence of moderate or severe pain 24 hours after a burns injury related procedure 
at Tygerberg Academic Hospital burns unit. These results were then compared with 
the results of a previous similar study in the same setting.  
 
The secondary objective was to audit the frequency of analgesia administered during 




















































Burns are a common form of injury leading to presentation at a health care facility. In 
2004, nearly 11 million people worldwide suffered burns severe enough to require 
medical attention. Burns may be caused by heat, radiation, radioactivity, electricity, 
friction or contact with chemicals.2 An annual estimated 265 000 deaths worldwide 
are caused by burns, mostly occurring in low- and middle-income countries. Non-
fatal burns are a leading cause of morbidity and prolonged hospitalization. It also 
causes disfigurement and disability, often with resulting stigma and rejection. Burns 
are one of the leading causes of disability-adjusted life-years (DALYs) lost in low- 
and middle-income countries.2 It is estimated that US$ 26 million is spent annually 
for care of burns from kerosene (paraffin) cook stove incidents in South Africa. It has 
further socio-economic impact due to lost wages, prolonged care for deformities and 
emotional trauma, as well as commitment of family resources.2 
 
According to most recent data, males and females have broadly similar rates for 
burns. Burn risk correlates with socio-economic status regardless of the level of 
development of countries. Specific risk factors for burns as listed by the World Health 
Organization, which are well known to be prevalent in South Africa are: 
 poverty, overcrowding and lack of proper safety measures 
 placement of young girls in household roles such as cooking and caring for 
small children  
 underlying medical conditions, including epilepsy, peripheral neuropathy, 
physical and cognitive disabilities, alcohol abuse and smoking 
 easy access to chemicals used for assault (such as in acid violence attacks)  






Patients with serious or extensive burns often have prolonged hospital admission as 
well as repeated surgical interventions. Surgery related to burns is often associated 
with severe and incompletely treated post-operative pain. Post-operative pain in 
developing countries has been reported to be higher than in developed countries.1 
Patients suffering burn injuries are at risk of developing opioid tolerance due to 
prolonged admission with long term opioid treatment.1,3 Tolerance is characterized 
by a reduced responsiveness to opioid agonists such as morphine and is manifested 
by needing to increase opioid doses to achieve the desired effect.4 As suggested in 
an article by Murray and Retief (2016), cost-effective ways to improve analgesia 
need to be found.  They recommend the targeting of populations with a higher 
incidence of post-operative pain and fully utilizing basic analgesic methods. 
Infrequent administration of analgesic agents was shown to be a possible contributor 
to uncontrolled pain. 1 
 
2.1.2 Mechanism of aggravated pain in burn injuries 
 
The early pain after a burn injury is due to direct stimulation and injury of the 
epidermal and dermal nociceptors. This leads to the transmission of nerve impulses 
by A-delta and C-fibers to the dorsal horn of the spinal cord. The magnitude of these 
impulses are modulated by the peripheral stimuli as well as descending influences 
from the brain.5 
 
Within minutes from the time of injury an inflammatory response is initiated. This 
leads to the release of numerous chemical irritants that sensitize and stimulate the 
nociceptors at the site of the burn injury for several days. This site remains painful 
and sensitive to mechanical and thermal stimuli – known as primary hyperalgesia. 
Tissues adjacent to the site of injury may undergo a change in sensitivity to 
mechanical stimuli known as secondary hyperalgesia. With the gradual subsiding of 
the inflammatory response, the quality of pain changes. The intensity of pain varies, 
being typically at its maximum in places of skin loss and tissue donor areas. The 
destruction of nerve endings in severe burns may lead to local insensitivity to pain. 






Four patterns of pain have been described in patients with burn injuries.  
 Background pain is the constant pain at rest and in motion. 
 Breakthrough pain is intense and sudden worsening of pain that is episodic.  
 Procedural pain is related to specific procedures e.g. dressing changes.  
 Post-operative pain is pain experienced following a surgical procedure e.g. 
debridement of skin, amputation or skin grafting.6 
 
2.1.3 Causes for inadequate analgesia in postoperative patients 
 
Continued or repeated pain stimuli in the setting of inadequate background or 
procedural analgesia gives rise to central nervous system adaptations. Pain signals 
and perception thereof become facilitated and amplified, causing hyperalgesia. 
Unfortunately these changes may become irreversible with time and then lead to 
chronic pain. Mechanisms involved in this wind-up are sensitization of peripheral 
receptors, an increase in excitability at the dorsal horn of the spinal cord involving N-
methyl-D-aspartate (NMDA) receptor systems as well as descending pathway 
activation.7 The use of pre-operative and intra-operative opiates, younger age, larger 
burn size and increased pre-operative pain is associated with more post-operative 
pain. Tolerance, which involves the physiologic adjustment to the analgesic effects of 
many analgesic agents, may be partially responsible for this phenomenon.8  
A lack of nursing knowledge regarding pain assessment and pain management 
strategies leads to the under treatment of pain in patients.9–11 Nursing reliance on 
their own subjective judgment is a barrier to effective management of patients’ pain. 
Nurses who have had additional focused education regarding pain management 
were found to have better knowledge about pain management.9 
 
The lack of integrating the current knowledge and practice of effective pain 
management by health care staff has negative effects on patient well-being.10  It has 
been shown that the use of systematic nursing pain assessment tools as well as pain 







2.1.4 Consequences of uncontrolled post-operative pain 
 
Burn pain is a very difficult form of acute pain to treat. Standard burn care is also 
likely to worsen background pain.13  Acute postoperative hyperalgesia will likely 
increase the amount of pain experienced by the patient. This then has the potential 
to increase the effects of subsequent and ongoing nociceptive inputs from the wound 
on the patient in the areas of stress, immunity and tissue-tropism. These effects 
increase the risk of complications, impair mobilization, prolong hospital admission 
and may cause other unwanted consequences following surgery.7 Examples of 
these include amongst others: decreased alveolar ventilation, pneumonia, 
hypertension, deep venous thrombosis (DVT), tachycardia, myocardial infarction and 
insomnia. Increased pain perception leads to increased analgesia use with the side 
effects thereof – well documented in the case of opioid use with respiratory, 
gastrointestinal and urologic side effects.7 
 
Pain can interfere with wound care and there is also an association with general 
emotional distress as well as long-term post-traumatic stress disorder.13 
Chronic pain is a well-recognized complication following burn injuries. Nerve tissue 
that was damaged and regenerate can give rise to complex neuropathic pain 
syndromes. In these the sensation of the painful stimulus far outlives its expected 
duration. Patients may experience hyperalgesia where there is an increased 
response to a painful stimulus and also allodynia where a normal innocent stimulus 
is perceived as painful. This problem can start early on after the initial injury and 
persist for many years thereafter. This chronic pain is often resistant to conventional 
analgesics. Chronic symptom severity is often related to burn size as well as number 
of skin graft procedures performed.14 
 
2.1.5 Methods of pain measurement 
 
Pain scales in use are the Visual analogue scale (VAS), Verbal numeric rating scale 
(VNRS), Verbal rating scale (VRS), Faces pain scale and PAINAD Scale. 15 The 
VAS is well validated for acute pain and post-operative pain.16–20 There is a good 
correlation between the 4 point categorical pain scale and the VAS.18,20,21 We 




do comparisons: (1) No Pain (0 - 5mm), (2) Mild Pain (5 - 40mm), (3) Moderate Pain 
(41 - 75mm) and (4) Severe Pain (76 - 100mm).1,22 VAS is the most sensitive to 
different pain intensities.23 No difference was found between the completion thereof 
by men or women21 and it can be used to rate current, most or average pain over a 
period (retrospective).18,23 
 
In a literature review by Coll (2003) based on established criteria, the VAS was found 
to be methodologically sound, conceptually simple, easy to administer and 
unobtrusive to the respondent.  On these grounds, the VAS seemed to be most 
suitable for measuring intensity of pain after day surgery.24  
In a multivariate analysis was found that none of the variables such as age, gender, 
and education level had significant effects on correlation between visual analogue 
scale and faces rating scale.25 The pain assessment tool for this study was the visual 
analogue scale.  
 
According to an article by Kelly (2001), the minimum clinically significant difference 
(MCSD) in VAS pain scores does not differ with the severity of the pain being 
experienced.  The overall MCSD in VAS score for the whole group was 12 mm. 
MCSD in VAS score for the “mild pain” group was 11mm, for the “moderate pain” 
group 14 mm for the severe pain group, 10 mm.26 
 
2.1.6 Approaches to post-operative pain in burns patients 
 
The goal of post-operative pain management is to have optimal pain relief while 
minimizing the side effects of the analgesia. Pre-emptive analgesia may decrease 
post-operative pain as well as decrease post-operative analgesia requirements.27  
Using a validated pain assessment tool to evaluate post-operative pain and 
managing the pain according to it, is strongly recommended by the American Pain 
Society.28 Anaesthesia for burn injuries as well as intensive care can form a 
significant part of the anaesthetic workload in the hospital with a burn center.   
 
Anaesthetists need an appreciation of analgesia management related to the 
pathophysiology of the burn, as their role in supporting analgesia for burn patients is 




usually present at their local hospitals first. Early appropriate management of burn 
pain have a significant impact on the later experience of pain.14 
 
Patients commonly suffer low-grade but persistent discomfort after initial treatment 
and between procedures. The nature of this has been repeatedly shown to be under-
appreciated even by experienced staff. It is difficult to treat adequately while aiming 
to minimize the patient’s exposure to side-effects. Adequate treatment is however 
essential to patient well-being.14 
 
In a review article by Norman and Judkins (2004), multimodal analgesia is 
advocated, using low dose oral opioids in combination with NSAIDs. Regular 
evaluation of extent of pain relief is required as is careful titration of analgesic 
doses,14 which is difficult in resource limited settings. The challenges surrounding the 
use of NSAIDs are mentioned later on in this literature review. Pre-emptive, regular 
dosing with analgesia combined with additional supplemental analgesia for the 
treatment of breakthrough pain is very effective in clinical practice.14 
 
Burn patients may not only suffer pain from the burn wound area and skin donor 
areas, but also from other related injuries. This is especially true in major or multiple 
injuries including fractures. Pain of co-existent abdominal injuries should be 
managed appropriately. Pain in a limb with circumferential burns may allude to 
compartment syndrome. Surgical decompression would then be required. Pain may 
also be a sign of cellulitis or pus formation in the recovery phase of burn injuries.  
 
Major burns may be associated with many complications including perforation of an 
abdominal viscus, colonic pseudo-obstruction, abdominal compartment syndrome 
and heterotopic bone deposition. A change in the type of pain or the magnitude of 
pain may be the first indication of a complication.14 
 
Pain management in burn patients remain challenging for the multidisciplinary team. 
An understanding of the complexity of the pathophysiological, psychological, and 
biochemical changes presented by a burn patient is of cardinal importance in 





Burn care staff may be reluctant to aggressively treat pain out of fear for creating 
dependence on opioids. Evidence does suggest though that opioid addiction does 
not occur more commonly in burn patients than in other populations who required 
opioids for treatment of acute pain – about 1 in 3000.13 
 
Paracetamol’s analgesic effects are due to action both centrally and peripherally. 
Used as the sole analgesic it has a weak analgesic effect but it has a very good 
synergistic effect when used in combination with opioids. It has few contraindications 
and an excellent risk profile. If not contraindicated, paracetamol should be used 
regularly in all burn patients at its maximal dose of 90 mg/kg/day with 4 or 6 hourly 
dosing.5 The different mechanisms of action of paracetamol involve the inhibition of 
activity of cyclo-oxygenase 2 (rather than 1), inhibition of central prostaglandin 
synthesis and the activation of descending serotonergic pathways.29 
 
The central analgesic effects of mu-opioid receptor agonists such as morphine are 
effected by actions on neurons within brain regions such as the mid-brain 
periaqueductal grey (PAG). Mu-opioid agonists inhibit GABAnergic influences on 
output projection neurons within the PAG.30 
Mu-opioid receptor agonists, such as morphine, are widely used effective analgesic 
agents. It is however commonly accompanied with unwanted side effects such as 
respiratory depression, sedation and constipation. They have a strong potential for 
addiction and often need to be used in escalating doses because of the rapid 
development of tolerance to the analgesic actions of the drugs.30 
 
Tramadol is a synthetic atypical opioid analgesic and acts by binding mainly to the 
mu-opioid receptor at the central nervous system.31 It also inhibits the reuptake of 
noradrenaline and serotonin and is therefore regarded as having a multimodal 
mechanism of action.32 It is relatively devoid of serious side-effects33 and has been 
shown to potentiate the analgesic effect of ketamine.31 It is well known that tramadol 
acts synergistically with paracetamol to provide an analgesic effect.32 
 
Ketamine is a non-competitive antagonist on the N-methyl-D-aspartate (NMDA) 
receptor which is a ligand gated calcium channel using glutamate as its major 




‘wind-up’ phenomenon which leads to central sensitization. Ketamine is therefore 
said to be effective in pathological pain states caused by this process.34 It is often 
used for conscious sedation during dressing changes in burn patients.35 
 
Ketamine at sub-anaesthetic doses of 0.1 -0.3 mg/kg is effective for pain relief. 
Ketamine at such low doses is safe, effective and when combined with opioids it 
improves pain management. Ahern et al (2015) did a large series reporting on the 
use of low dose ketamine for pain relief in an emergency department (ED) setting. 
They found it to be feasible and safe for the treatment of a wide variety of painful 
conditions. The adverse event rate was 6% overall, which is lower than the rate of 
that of opioids in hospitalized patients. The adverse events were easily identified and 
managed by ED staff. Furthermore none of the adverse events had caused harm or 
changed disposition. There were no reported incidents of apnea, laryngospasm, 
hypertensive emergency, or cardiac arrest. They concluded that low dose ketamine, 
either used alone or in combination with other pain medications, in a diverse ED 
patient population as a primary or rescue analgesic appears to be safe and feasible 
for the treatment of many types of pain.36 
 
In addition to prevention of awareness and recall in anaesthetized patients, ketamine 
also possesses anti-inflammatory and anti-tumour actions. It also potentiates opioid 
analgesia and prevents opioid induced acute tolerance and possibly also opioid 
induced spinal ischaemia after cross clamping of the aorta.3 
 
A review by Carstensen and Moller (2010) of randomized, double-blinded clinical 
trials where ketamine was added to morphine in intravenous Patient Controlled 
Analgesia (PCA) for postoperative pain, found that the ketamine–morphine 
combination could significantly reduce pain scores, cumulative morphine 
consumption, and postoperative desaturation in patients undergoing thoracic surgery 
compared to the use of intravenous morphine only PCA. This effect was less clear in 
orthopaedic and abdominal surgery.37  Opioid tolerance and hyperalgesia are of 
particular importance in patients suffering from intractable severe pain due to 
trauma, malignancy or neuropathy. Opioid tolerance and dependence may result 





Ketamine is rapidly metabolized in the liver and lung to norketamine. Norketamine 
has been reported to have anti-nociceptive actions in addition to enhancing 
morphine’s anti-nociceptive action to thermal nociception, peripheral neuropathy, 
and tonic inflammatory pain. Norketamine also blocked tolerance.38 Immuno-
inhibitory effects of ketamine were found to be partly due to inhibition of Transcription 
Factor Activator Protein-1 and Nuclear Factor-kB (NF-kB), these play a role in 
regulation of the production of pro-inflammatory mediators.3    
 
In an article by Jouguelet-lacoste et al. (2015) it was reported that four meta-
analyses out of five concluded that ketamine was safe to be administered as it did 
not increase the incidence of adverse side effects, this was irrespective of the route 
of administration. The meta-analysis that did find an elevated occurrence of side 
effects showed them to be all minor psychotomimetic effects. These were short term 
and reversible, ceasing when stopping the ketamine infusion or using 
benzodiazepines. The reviews reported ketamine had no impact on sedation 
scores.39 Ketamine was found to decrease the incidence of nausea and vomiting.39,40  
In the 39 clinical trials of low dose ketamine (IV infusion rate of less than 1.2 mg/kg/h 
and bolus dose less than 1 mg/kg) included in the review by Jouguelet-lacoste et al., 
there were no occurrence of liver toxicity. Their review showed ketamine reduced 
opioid consumption, enhanced post-operative analgesia and that low-dose ketamine 
is safe to administer. Ketamine’s benefit is believed to be predominantly from a 
reduction of opioid burden more than a reduction of pain scores. The drug’s optimal 
dose and regimen of administration, however, remain unknown.39 
 
Ketamine gives an improved quality of pain control as well as decrease in the 
consumption of opioids. Nightmares and hallucinations are more commonly 
encountered but sedation not. Ketamine had significant analgesic benefit in 
procedures involving the thorax and upper abdomen but not for tonsillectomy, dental, 
head and neck surgery. The perioperative use of adjuvant Ketamine for analgesia 
was shown to be relatively safe with no serious side effects. Ketamine is known for 
its neuropsychiatric side effects which are often a drawback for the routine use of 
this drug. These side effects were more prevalent with treatment efficacy. Most 
individual articles found these effects to be not statistically significant and many 




Stirling, Mckay & Lim (2011) proposed that there is little to be gained from further 
randomized control trials evaluating ketamine’s role in surgery known to produce 
mild pain, instead further studies should focus studying patients at risk for severe 
postoperative pain and respiratory depression and on investigating the rescue of 
patients who continue to suffer severe postoperative pain despite routine treatment.   
Subgroup analyses has shown the greatest opioid sparing effect of ketamine occurs 
when high maximum postoperative pain scores are encountered.40 
 
Nonsteroidal anti-inflammatory drugs (NSAIDs) have analgesic, anti-inflammatory, 
and antipyretic properties.5 The action of NSAIDS include reversibly inhibiting cyclo-
oxygenase as well as inhibiting prostaglandin production, and sometimes by 
inhibiting the lipoxygenase pathway.30 NSAIDS work very well when combined with 
opioids. They decrease central hyperalgesia, act synergistically with opioids and are 
also opioid sparing.5,41 
  
The side effects of NSAIDs that limit their use in burns are as follows: 
 
 1) Mucosal irritation and ulceration of stomach.5,41 
 2) Platelet dysfunction that may cause bleeding problems.5,41  
 3) Impaired renal function that may lead to renal failure.5,41 
 4) Alteration of the concentration of protein-bound medication (eg. warfarin).41 
 
For these reasons, NSAIDs are not routinely used in the Tygerberg Hospital burns 
unit. 
 
2.1.7 Compliance with prescribing analgesia and issuing analgesia 
 
Poor adherence by nursing personnel to issue analgesia according to the 
prescription chart is a known phenomenon. This is more frequently encountered 
when opioids are used. Reasons for this are their anxiety regarding respiratory 
depression and the possibility of patient addiction developing. The pressure of time 
on nurses also hinders compliance to prescription orders. The ease of administering 
non-opioid analgesia is a further reason why opioids are poorly administered despite 





To improve the treatment of pain, pain needs to be routinely assessed and once 
identified, appropriate analgesia needs to be administered.43 Regular monitoring of 
pain as the 5th vital sign in addition to blood pressure, pulse, respiratory rate and 
temperature forms part of the South African Acute Pain Guidelines.15 
Educational interventions are of great importance to improve the standard of care 
and regular audits are recommended in order to maintain greatest benefit.44,45 
Posters can be used to communicate a change in policy and for educational 
purposes.46 
 
2.1.8 Interventions made at Tygerberg burns unit 
 
Several changes have been made by the Department of Anaesthesiology and 
Critical Care following the study of Murray and Retief in the identified high risk 
patient group of burns.1 Previously there was no formal pain monitoring but it has 
subsequently become part of the monitoring of patients’ vital signs by the nursing 
staff.  Analgesia was not always administered frequently but subsequent training of 
nursing staff has focused on creating awareness of pain as well as improving 
compliance to prescribed analgesia. While there was no standardised prescription of 
analgesia by anaesthetists, there is now a standardised analgesia protocol. 
 
The comprehensive analgesia management plan is essentially made up of the 
following: 
 
 Posters are displayed in the burns unit as well as in the burns theatre with the 
protocol for analgesia prescription on it (Appendix F). 
 Pain protocol (pre-operative): 
o Patients receive a premedication of morphine 5 - 10mg intramuscular 
or subcutaneously.  







 Pain protocol (intra-operative): 
o Dosing of morphine is done by the anaesthetist and is individualized 
according to the patient’s opioid history in the ward prior to the surgery, 
estimated body mass index (BMI) as well as other comorbid conditions. 
o Titration of intravenous morphine intra-operative is done against the 
vital signs and also the extent of spontaneous breathing when not 
muscle-relaxed.  
o Patients receive an intravenous bolus dose of ketamine 0.25 – 0.5 
mg/kg intra-operatively, with the option of repeating this if deemed 
necessary by the anaesthetist.  
o The anaesthetist may consider an intravenous infusion of ketamine 1-
2mg/kg/hour for the duration of the surgery. 
o Patients who did not receive paracetamol as a premedication may 
receive intravenous paracetamol (15mg/kg to a maximum of 1 gram) 
intra-operatively, or in the recovery room directly after the surgery. 
 Pain protocol (post-operative): 
o Patients receive oral paracetamol at a dose of 20mg/kg (maximum 1g) 
every 6 hours, as well as oral tramadol 50mg 6 hourly.  
o Where available, patients can receive intravenous paracetamol 
(15mg/kg, maximum 1g) 6 hourly rather than orally. 
o Routine intramuscular / subcutaneous morphine 10mg every 4 hours 
post-operatively, according to the pain score reported by the patient, 
the dose is once again adjusted up or down according to the opioid 
history as well as response to opioids pre-operatively, BMI and the 
comorbid conditions.  
o Naloxone is readily available in the Burns unit for use in the case of 
opioid overdosing.  
o Post-operatively patients are prescribed ketamine 0.25mg/kg 








 Ongoing nursing education with the aim of:  
o Increasing awareness of the fact that patients experience pain. 
o Improving compliance to the prescribed analgesic regimen. 
o Motivation to continue with pain scores as part of routine observations 
and correctly acting upon it. 
 Formal pain monitoring: 
o Dedicated postoperative observation chart where pain scores are 
documented. 
o Guidelines on how to act upon unacceptably high pain scores. 
 
The analgesia protocol is not there to replace clinical judgement of the attending 
clinicians and an emphasis is placed on evaluating the analgesic needs of the 
patient with the analgesia protocol serving as a framework. Deviations from the 










3.1 Methodology and Materials 
 
This was a follow-up observational study of the burns population identified as high 
risk for poorly controlled postoperative pain according to Visual Analogue Scale 
(VAS) measurement in a study done by Murray and Retief in 2012 (published in 
2016) when there was no standard analgesic protocol.1 
 
A repeat sample of the burns population in the burns unit of Tygerberg Academic 
Hospital was evaluated with regards to their experience of postoperative pain in the 
first 24 hours after wound debridement or skin grafting. The time interval between 
the implementation of the new protocol and the start of the audit was five months.  
The study population included all patients that were scheduled for surgery above the 
age of 12 years in the Burns Unit.  
 
Exclusion criteria were as follows: 
 Age younger than 13 years. 
 Visual or intellectual impairment to such an extent that the patient is unable to 
understand his/her role in participation in the study,  or where he/she is 
unable to give informed consent via an interpreter. 
 Psychosis or delirium. 
 Patients with a contra-indication for the medication used in the comprehensive 
analgesia management plan. 
 Clinically unstable patients in whom the completion of the questionnaire may 
not be possible. 
 Patients who were kept sedated or intubated and ventilated at the end of the 
surgical procedure and are therefore not able to give an accurate account of 
the post-operative period of pain relief. 
 Patients arriving in the recovery unit before 7h00 am or after 18h00 pm. 
 
The pain assessment tool that was used in this study as well as the initial study in 




women. A difference in VAS scores of 12 mm is regarded as the minimum clinically 
significant difference according to the literature. 26 
 
Data was collected on a 100 mm paper VAS by the investigators in three of the local 
languages (English, Afrikaans and isiXhosa).  Patients were interviewed as close as 
possible to 24 hours after surgery, after informed consent was obtained. VAS scores 
for worst pain in the first 24 hours postoperative as well as the current level of pain at 
the time of the interview were obtained.  The number of analgesic doses received for 
different oral and parenteral analgesic drugs were obtained from the prescription 
charts in patient folders.   
 
3.2 Statistics and power analysis 
 
The sample size calculation was subjective to the sample size from the previous 
study by Murray and Retief, which had 57 participants and would form the first study 
group. We would not have the power to detect a 12 mm difference as is the minimal 
clinically significant number, but we would be able to detect a difference of 18 mm, 
which we expected to obtain. The standard deviation of 31 mm from the previous 
study was used to calculate the sample size to detect a predicted difference of 18 
mm between the initial and new mean VAS pain scores. If a power of 0.80 and an 
alpha value of 0.05 are used during parametric methods (Two sided T-test), the 
sample size needed to detect an 18 mm difference between two means in a 
population with a standard deviation of 31 mm would be 51.  These values were 
obtained by using the STATA 14 statistical software. 
 
Due to the skewness and ordinal character of pain scale data, it is recommended 
that medians with non-parametric statistics should be used. The study population 
should therefore be increased with 10%, making 57 patients in each group adequate 
to detect an 18 mm difference in medians.  
 
Data was captured on an Excel spread sheet. Patient confidentiality was maintained 
with the name of the patients and study results not being in the same document. 
Data was analyzed with the help of the Biostatistics Unit at the Tygerberg Campus of 




The outcome was measured as a difference in post-operative VAS scores between 
the reference and follow-up groups. Data was described and compared using 
median values (with confidence intervals), interquartile ranges and ranges. A Chi 
square test was done to detect the probability of a difference to be by chance. A p-
value of below 0.05 was deemed statistically significant. The median difference 
between the medians was calculated with 95% CI. 
 
Data from the reference and follow-up groups were dichotomized into two groups. 
The first group included no or mild pain (0-40mm VAS score) and the second group 
moderate to severe pain (41-100 mm VAS score). Odds Ratios with 95% confidence 
intervals and Numbers Needed to Treat were subsequently calculated. A Chi square 

















4.1.1 Descriptive statistics 
 
A total of 64 patients were enrolled in the audit. Data was collected over a period of 
12 weeks from the 3rd of May 2017 to the 20th July 2017. Patients were interviewed 
as close as possible to 24 hours postoperatively in the Burns Unit of Tygerberg 
Academic Hospital. Only patients who complied with the criteria listed above were 
approached to participate. There was a 100% compliance rate with no one refusing 
to be interviewed. 
 
Table 1: Age summary of different groups 
 
  2017 2012 
Mean age (years) 34 34 
SD 12  12 
Range 14 to 67 14 to 70 
 
The mean age of participants in 2017 as well as 2012 was 34 years. The standard 
deviations for both groups were 12. The range for age in 2017 was 14 to 67 compared 


















There were 43 males and 21 females in the study group of 2017, 
compared to 46 males and 11 females in 2012. The p-value for 
gender comparison between the groups is 0.09. 
  
4.2 Worst pain scores 
 
































In 2017 the range for worst pain scores as indicated on a VAS was 2mm to 98mm. 
The 25th percentile was 19.5mm and the 75th percentile was 79mm. The median 
value was 61mm. The 95 percent confidence interval for the median value was 
46.6mm to 69.0mm. In 2012 the range for worst pain scores as indicated on a VAS 
was 0mm to 100mm. The 25th percentile was 45mm and the 75th percentile was 
80mm. The median value was 67mm. The 95 percent confidence interval for the 
median value was 51.7mm to 73.3mm. 
 
Table 2: Categorisation of worst pain scores 
 
  2017   2012  
 N % 95% CI n % 95% CI 
no pain 6 9.4 4.2 - 19.7 6 10.5 4.7 - 22.0 
mild 13 20.3 12.0 - 32.3 8 14.0 7.0 - 26.1 
moderate 25 39.1 27.7 - 51.8 22 38.6 26.6 - 52.1 
severe 20 31.2 20.9 - 43.9 21 36.8 25.1 - 50.4 
total 64 100  57 100  
 
Pain was categorised into the following groups according to the VAS scores: (1) No 
Pain (0 - 5mm), (2) Mild Pain (5 - 40mm), (3) Moderate Pain (41 - 75mm) and (4) 
Severe Pain (76 - 100mm).  When evaluating the worst pain experienced in the first 
24 hours postoperatively in the 2017 group that had 64 patients, the results were as 
follows. There were 6 patients with no pain, representing 9.4% of the group, with a 
confidence interval of 4.2 to 19.7. There were 13 patients with mild pain, 
representing 20.3% of the group, with a confidence interval of 12.0 to 32.3. There 
were 25 patients with moderate pain, representing 39.1% of the group, with a 
confidence interval of 27.7 to 51.8. There were 20 patients with severe pain, 
representing 31.2% of the group, with a confidence interval of 20.9 to 43.9. When 
evaluating the worst pain experienced in the first 24 hours postoperatively in the 
2012 group that had 57 patients, the results were as follows. There were 6 patients 
with no pain, representing 10.5% of the group, with a confidence interval of 4.7 to 22. 
There were 8 patients with mild pain, representing 14% of the group, with a 




representing 38.6% of the group, with a confidence interval of 26.6 to 52.1. There 
were 21 patients with severe pain, representing 36.8% of the group, with a 
confidence interval of 25.1 to 50.4. The p-value for comparing worst pain scores 
between the two groups is 0.4. 
 




When evaluating the worst pain experienced in the first 24 hours postoperatively, 
9.4% of patients in 2017 had no pain compared to 10.5% in 2012. Mild pain was 
reported by 20.3% in 2017 compared to 14% in 2012. Moderate pain was reported 
by 39.1% of patients in 2017 compared to 38.6% in 2012. Severe pain was reported 
by 31.2% of patients in 2017 compared to 36.8% in 2012. The p-value for comparing 






































Table 3: Dichotomisation of worst pain scores 
 
 2017 2012 
 n % n % 
No- / mild pain 19 29.7 14 24.6 
Moderate- / severe 
pain 
45 70.3 43 75.4 
Total 64 100 57 100 
 
In 2017 there were 19 patients (29.7%) that reported no- or mild worst pain in the 
first 24 hours and 45 (70.3%) that had moderate to severe pain. In 2012 there were 
14 patients (24.6%) with no to mild pain and 43 (75.4%) with moderate to severe 
pain. The p-value for comparing worst pain between groups after dichotomisation 
equals 0.53 
 




In 2017 there were 29.7% of patients that reported no or mild worst pain in the first 
24 hours and 70.3% that had moderate to severe pain. In 2012 there were 24.6 % of 
patients with no to mild pain and 75.4% with moderate to severe pain. The p-value 































Table 4: Odds Ratio for moderate / severe pain in 2017 compared to 2012 
 
 Odds Ratio 95% CI 
Moderate / severe worst 
pain in 2017 vs 2012 
0.77 0.34 – 1.73 
 
The Odds Ratio for having moderate or severe worst pain in 2017 as opposed to 
2012 was 0.77 with a 95% confidence interval of 0.34 to 1.73.  
 
Table 5: Number needed to treat in 2017 for worst pain 
 
 Number Needed to Treat 
Moderate / severe worst pain  20 
 
The number of patients needed to treat with the protocol of 2017 to prevent one 
patient from having moderate/severe worst pain compared to 2012 is 20.  
 
4.3 Pain scores at 24 hours 
 






In 2017 the range for current pain scores as indicated on a VAS was 0mm to 97mm. 
The 25th percentile was 4.5mm and the 75th percentile was 53mm. The median 
value was 26.5mm. The 95 percent confidence interval for the median value was 
12.3mm to 35.4mm. In 2012 the range for current pain scores as indicated on a VAS 
was 0mm to 100mm. The 25th percentile was 13mm and the 75th percentile was 
50mm. The median value was 30mm. The 95 percent confidence interval for the 
median value was 19.1mm to 41.7mm. 
 
Table 6: Categorisation of current pain scores 
 
  2017   2012  
 n % 95% CI n % 95% CI 
no pain 17 26.6 17.0 - 39.0 13 22.8 13.5 - 35.9 
mild 25 39.1 27.7 - 51.8 23 40.4 28.2 - 53.9 
moderate 15 23.4 14.5 - 35.7 18 31.6 20.6 - 45.1 
severe 7 10.9 5.2 - 21.6 3 5.3 1.6 - 15.6 
total 64 100  57 100  
 
Pain was categorised into the following groups according to the VAS scores: (1) No 
Pain (0 - 5mm), (2) Mild Pain (5 - 40mm), (3) Moderate Pain (41 - 75mm) and (4) 
Severe Pain (76 - 100mm). When evaluating the pain experienced at the time of the 
interview 24 hours postoperatively in the 2017 group that had 64 patients, the results 
were as follows. There were 17 patients with no pain, representing 26.6% of the 
group, with a confidence interval of 17.0 to 39.0. There were 25 patients with mild 
pain, representing 39.1% of the group, with a confidence interval of 27.7 to 51.8. 
There were 15 patients with moderate pain, representing 23.4% of the group, with a 
confidence interval of 14.5 to 35.7. There were 7 patients with severe pain, 
representing 10.9% of the group, with a confidence interval of 5.2 to 21.6. When 
evaluating the pain experienced at the time of the interview 24 hours postoperatively 
in the 2012 group that had 57 patients, the results were as follows. There were 13 
patients with no pain, representing 22.8% of the group, with a confidence interval of 
13.5 to 35.9. There were 23 patients with mild pain, representing 40.4% of the group, 




pain, representing 31.6% of the group, with a confidence interval of 20.6 to 45.1. 
There were 3 patients with severe pain, representing 5.3% of the group, with a 
confidence interval of 1.6 to 15.6. The p-value for comparing current pain scores 
between the two groups is 0.89. 
 




When evaluating the current pain experienced in the first 24 hours postoperatively, 
26.6% of patients in 2017 had no pain compared to 22.8% in 2012. Mild pain was 
reported by 39.1% in 2017 compared to 40.4% in 2012. Moderate pain was reported 
by 23.4% of patients in 2017 compared to 31.6% in 2012. Severe pain was reported 
by 10.9% of patients in 2017 compared to 5.3% in 2012. The p-value for comparing 






































Table 7: Dichotomisation of current pain scores 
 
 2017 2012 
 n % n % 
No/mild pain 42 65.6 36 63.2 
Moderate/severe 
pain 
22 34.4 21 36.8 
Total 64 100 57 100 
 
In 2017 there were 42 patients (65.6%) that reported no or mild current pain in the 
first 24 hours and 22 (34.4%) that had moderate to severe pain. In 2012 there were 
36 patients (63.2%) with no to mild pain and 21 (36.8%) with moderate to severe 
pain. The p-value for comparing current pain at 24 hours postoperatively between 
two groups after dichotomisation is 0.77. 
 




In 2017 there were 65.6% of patients that reported no or mild current pain in the first 
24 hours and 34.4% that had moderate to severe pain. In 2012 there were 36 





























comparing current pain at 24 hours postoperatively between two groups after 
dichotomisation is 0.77. 
 
Table 8: Odds Ratio for moderate / severe pain in 2017 compared to 2012 
 
 Odds Ratio 95% CI 
Moderate / severe current 
pain in 2017 vs 2012 
0.9 0.43 – 1.9 
 
The Odds Ratio for moderate or severe current pain in 2017 as opposed to 2012 
was 0.9 with a 95% confidence interval of 0.43 to 1.9. 
 
Table 9: Number needed to treat in 2017 for current pain 
 
 Number Needed to Treat 
Moderate / severe current pain 34 
 
The number of patients needed to treat with the protocol of 2017 to prevent one 
patient from having moderate/severe current pain at 24hours postoperatively 
compared to 2012 is 34. 
 
4.4 Compliance to pain scores and analgesia administration: 
 
Table 10: Amount of documented pain scores (2017 only) 
 
Mean 1.38 
Standard Deviation 1.6 
Range 0 - 5 
 
The mean amount of pain scores done in the 2017 group was 1.38 with a standard 





4.5 Morphine admistration 
 
Table 11: Morphine premedication received (2017) 
 
 n % 
Yes 30 47 
No 34 53 
Total 64 100 
 
In the 2017 group, 30 patients received a premedication of morphine and 34 did not, 
this represented 47% and 53% of the study population respectively.  
 




The median VAS score for worst pain was 52mm for those who received a morphine 
premedication, compared to 64mm for those who did not, p-value is 0.21. The 
median VAS score for current pain was 22mm for those who received a morphine 

































 Table 12: Morphine doses received in first 24 hours post-operatively (2017) 
 
Mean 2.8 
95% CI 2.5 – 3.1 
Standard Deviation 1.25 
Range 0 – 5 
Frequency (24h / mean) 8.5 hourly 
Patients who received no morphine (n) 3 
 
In 2017, patients received a mean of 2.8 morphine doses in the first 24 hours post-
operatively with a 95% confidence interval of 2.5 to 3.1. The standard deviation was 
1.25 and the range 0 to 5. This equates to a dose of morphine administered every 
8.5 hours. There were 3 patients who did not receive any morphine post-operatively. 
 




In the study of 2017, in the first 24 hours post-operatively there were 3 patients that 
received no morphine. 8 Patients received a single dose while 11 received 2 doses. 











were 3 patients that received 5 doses of morphine in the first 24 hours post-
operatively. 
4.6 Ketamine administration 
 
Graph 10: Ketamine doses received  
 
  
There was only patient out of 64 that received a dose of ketamine for post-operative 
pain in the first 24 hours. 
 
4.7 Paracetamol 
     
Table 13: Paracetamol doses received in first 24 hours post-operatively 
 
Mean (Confidence interval) 3.1 
95% CI 2.8 - 3.4 
Standard Deviation 1.2 
Range 0 - 6 
Frequency (24h / mean) 7.7 hourly 










The mean amount of paracetamol doses received in the first 24 hours post-
operatively was 3.1 with a 95% confidence interval of 2.8 to 3.4. The standard 
deviation was 1.2 and the range 0 to 6. This equates to a dose of paracetamol 
administered every 7.7 hours. There was only one patient who received no 
paracetamol post-operatively. 
 




In the first 24 hours post-operatively, there was 1 patient that received no 
paracetamol and 6 that received a single dose. A total of 13 patients received 2 
doses and 15 received 3 doses. There were 23 patients that received 4 doses and 5 
patients that received 5 doses. There was 1 patient that received 6 doses in the first 
24 hours post-operatively. 
 
4.8 Tramadol administration 
 
Table 14: Tramadol doses received in first 24 hours post-operatively 
 
Mean (Confidence interval) 2.2 
95% CI 1.9 - 2.5   












Range 0 - 4 
Frequency (24h / mean) 10.9 hourly 
Patients who received no tramadol (n) 9 
 
The mean amount of tramadol doses received in the first 24 hours post-operatively 
was 2.2 with a 95% confidence interval of 1.9 to 2.5. The standard deviation was 1.1 
and the range 0 to 4. This equates to a dose of tramadol administered every 10.9 
hours. There were 9 patients who received no tramadol post-operatively. 
 
Graph 12: Number of tramadol doses received per patient 
 
 
In the first 24 hours post-operatively, there were 9 patients that received no 
paracetamol and 5 that received a single dose. A total of 18 patients received 2 
doses and 28 received 3 doses. There were 4 patients that received 4 doses in the 




















4.9 Patient satisfaction 
 

















































































3 M Y 2 3 3 0 78 75 0 
10 F Y 3 4 3 0 41 43 0 
19 F Y 3 3 3 0 94 92 4 
49 F N 4 4 3 0 89 88 2 
53 M N 2 1 1 0 77 58 2 
 
Two male and three female patients were not satisfied with their analgesia. Two of 
these patients did not receive a premedication of morphine. All the patients received 
morphine, paracetamol and tramadol in the first 24 hours after surgery. None of 
these patients received ketamine during that period. Worst pain scores varied 
between 41 and 94, while current pain scores varied between 43 and 92. Only three 





















59 patients indicated their satisfaction with the analgesia they received and five were 
unhappy with it. 
 













































In this study of 2017, the mean age of participants was 34 years with a range of 14 
to 67 years old. This compares favourably with the data set from 2012 where the 
mean age of the 57 participants was also 34 years and the range was 14 to 70 years 
old. A two sample t-test was done to test if the two population means are equal. The 
p-value was 0.96 which indicates that there was no statistical difference shown 
between the two means. 
 
There was a clear male dominance in 2017 with 43 males and 21 females (67.2% 
versus 32.8%). The 2012 group also had a male dominance with 46 males and 11 
females (80.7% versus 19.3%). The p-value as calculated by the Pearson Chi 
Square test was 0.09, indicating that there is no statistical significant difference 
between the two groups in terms of gender distribution. 
 
5.2 Pain scores 
 
The median worst pain score in 2017 was 61mm (95% CI of 46 - 69) compared to 
67mm in 2012 (95% CI of 50 - 75). This is only a difference of 6 mm and is less than 
the 12 mm clinically significant number or the 18 mm we had predicted beforehand. 
The p-value as determined by the two-sample Wilcoxon rank-sum (Mann-Whitney U) 
test for the worst pain scores between the 2012 and 2017 data was 0.4 which is 
greater than 0.05. The median difference between medians was -5 mm (95%CI -6 to 
-3). It was therefore statistical significant (not including zero) according to this 






The median current pain score in 2017 was 26.5 mm (95%CI of 11 - 36) versus 
30mm in 2012 (95% CI of 18-44), a difference of only 3.5mm. The p-value according 
to the two-sample Wilcoxon rank-sum (Mann-Whitney) test for current pain scores 
between the 2012 and 2017 data was 0.89, again much greater than 0.05. The 
median difference between medians was -1 mm (95% CI of -3 to 1). It was therefore 
not statistically significant (included zero). 
 
A Pearson Chi square test was done to detect the probability of any difference in the 
Worst Pain category between 2012 and 2017 data to be due to chance after 
dichotomisation into the no/mild and moderate/severe groups. The p-value of 0.53 is 
much higher than the predetermined acceptable value of 0.05. This proves that there 
was no statistical significant difference found between the 2012 and 2017 groups in 
this regard. 
 
When considering worst pain scores, the odds ratio for having moderate/severe pain 
in 2017 versus 2012 was 0.77 with a 95% confidence interval of 0.34 to 1.73 that 
includes one, thus meaning there is no real difference in outcome. 
  
When looking at the Numbers Needed Treat in 2017 to prevent one patient from 
having moderate/severe pain compared to 2012 by worst pain score, it is 20. This is 
much more than the range of 2 to 3 that is usually considered to reflect very effective 
treatment.47 
 
A Pearson Chi square test was done to detect the probability of any difference in the 
current pain category between 2012 and 2017 data to be due to chance after 
dichotomisation into the no/mild and moderate/severe groups. The p-value of 0.77 is 
much higher than the predetermined acceptable value of 0.05.This proves that there 
was no statistical significant difference found between the 2012 and 2017 groups in 
this regard. 
 
When comparing current pain scores, the odds ratio for having moderate/severe pain 
in 2017 as opposed to 2012 was 0.9 with the 95% confidence interval of 0.43 -1.9 




When looking at the numbers needed to treat in 2017 to prevent one patient from 
having moderate/severe pain compared to 2012 by current pain score it is 34, again 
much higher than the range of two to three that is considered to be very effective 
according to McQuay and Moore.47 
 
5.3 Morphine, Ketamine, Paracetamol and Tramadol administration 
 
The prescription of morphine and or paracetamol as a premedication was left up to 
the clinical judgement of the attending anaesthetist. Factors involved in the decision 
of the type of premedication, if any, that would be prescribed was the type and extent 
of surgery, the time spent in the ward on analgesics pre-operatively, the co-morbid 
conditions of the patient as well as the size of the patient. A total of 30 patients 
received intramuscular morphine as a premedication (47%). The administration of a 
morphine premedication did not result in a statistical significant decrease in VAS 
scores for both worst pain and current pain.  
 
Patients who received a premedication of morphine had a median worst pain score 
of 52mm compared to 64mm in those without the premedication. A Two-sample 
Wilcoxon rank-sum (Mann-Whitney) test was done to determine whether there is any 
difference between the worst pain scores between the group two groups. The 
calculated p-value was 0.21. There could have been selection bias as patients who 
were expected to have more pain, probably received morphine. 
 
The median current pain score for those who did receive a morphine premedication 
was 22mm, compared to 28mm for those who did not. A Two-sample Wilcoxon rank-
sum (Mann-Whitney) test was done to determine whether there is any difference 
between the current pain scores between the group that did receive morphine 
premedication and the group that did not. The calculated p-value was 0.26 for the 
current pain outcome. 
 
Administration of oral analgesia appears to be good, with patients receiving at least 
one dose of paracetamol in 98% of cases and at least one dose of tramadol in 86% 
of cases. However, when we examine the mean doses of analgesia drugs received, 





If paracetamol had been given intra-operatively or at the end of surgery in the 
recovery room, then we would expect that patients would receive a further four 
doses of paracetamol in the first 24 hours post-op (a dose at 6, 12, 18 and 24 hours 
post-op). Instead of receiving four doses, the mean amount of doses received was 
3.1. There were some patients that received a single dose of intravenous (IV) 
paracetamol in the recovery room, those numbers are included in the quoted figures 
for paracetamol doses received post-operatively as the specific amount of patients 
who received IV paracetamol was not documented as part of the data collection. 
 
For tramadol we would expect to see three to four doses in the first 24 hours if it had 
been administered six to eight hourly, the mean however was only 2.2.  Morphine 
was administered at a mean of 2.8 doses, again much less than the expected four to 
six doses in the first 24h post-op, had it been given four to six hourly. 
  
Even though the morphine was prescribed in an “as needed” (prn) fashion, the 
results of the audit show that patients in 2017 experienced similar pain to those in 
2012. One has to consider the contribution that infrequent dosing of morphine as 
well as the oral agents had on this. It is only logical to reason that infrequent 
administration of analgesia played a role in the poor outcomes with regards to pain 
scores. 
 
Ketamine as an analgesic agent was essentially ignored. Only one out of the 64 
patients in the study group received a single dose of ketamine in the first 24 hours 
post-operatively. The other 63 patients received no ketamine at all despite the pain 
scores showing that many patients would have qualified for the use thereof had the 
protocol been followed correctly.  
 
It was agreed upon by the members of the Department of Anaesthesiology and 
Critical Care to complete the nursing instruction form (Appendix G) so that nursing 
staff was allowed to administer a prescribed dose of ketamine if the patient indicated 
a score of four or more out of ten, based on a numeric rating scale (NRS), at least 
one hour after a dose of morphine was given to treat pain. Although the NRS is 




questionnaire, it would equate to 40mm on the VAS. Of note is the fact that 45 out of 
the 64 patients indicated a worst pain score of 40mm or more in the first 24h post-op 
and 22 reported a VAS of 40mm or more for current pain at 24h post-op. It is not 
possible to make accurate calculations on how frequently ketamine should have 
been administered based just on the scores indicated by patients on our 
questionnaire 24 hours after surgery.  
 
5.4 Strengths and limitation of the study 
 
There are multiple other factors required that cannot be elucidated from the data we 
have available. Acknowledging these limitations, it is still reasonable to accept that 
there were a significant amount of patients who did qualify to receive ketamine for 
analgesia, but never did so. 
 
Only 34 out of the 64 patients had any documentation of pain scores post-operatively 
(53%), with a mean of only 1.4 pain scores per patient enrolled in the study. There 
were only 24 patients who had more than one documented pain score (38%). As 
already pointed out, the frequency of administration of oral drugs was not optimal. 
Parenteral morphine administration was also infrequent and ketamine as an 
analgesic agent was essentially ignored. It is therefore clear that compliance with the 
new protocol was very poor. 
 
It was interesting to analyse the data of the five patients who indicated that they were 
not satisfied with the prescribed analgesia. The worst pain scores (in millimetres) of 
these patients were 78, 41, 94, 89 and 77 respectively. The details of their data are 
shown in table number 15 above. 
 
Of note is the finding that 16 out of the 20 patients who had severe pain (worst pain 
score of 75mm or more) indicated that they were indeed satisfied with the analgesia 
they received. This finding proves that the experience of pain is truly subjective. The 
International Association for the Study of Pain (IASP) defines pain as “an unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, 




that shows that the emotional part of pain experience may well differ between 
patients who indicated similar worst pain scores. 
 
Consideration should be given to the expectation of patients regarding the amount of 
pain they will have after surgery. It might well be that patients expect to have a lot of 
pain after a surgical procedure and therefore they still report satisfaction with the 
analgesia received despite worst pain scores indicating that many of them had 
unacceptable high levels of pain.  
 
By better educating patients that they need not be in suffering postoperatively and 
about the availability of proper and safe analgesia postoperatively, patients may be 
empowered to request rescue analgesia when routinely administered treatment fails 
to provide adequate analgesia. Patient expectations have to be explored to 
determine what their needs are while in hospital. This would however add to the 
heavy burden of the already limited amount of nursing staff. It would address the 
emotional aspect of patients’ well-being and with pain also having an emotional 
component, it might well be a very valuable treatment target. 
 
We need to ask whether the method of implementation of the new protocol was 
effective. Despite multiple contact sessions with nursing staff and the efforts made to 
involve staff of different shifts and the opportunities created to allow staff members to 
ask questions, there was still poor compliance. During the contact sessions that 
nursing staff had with members of the Department of Anaesthesiology and Critical 
Care, many questions were answered and uncertainties clarified.  
 
Nursing staff had been excited about the new protocol. They felt that they would be 
empowered to treat pain more effectively and have a means of better assessing the 
level of pain that the patients were experiencing. They admitted to being 
apprehensive of giving morphine frequently in fear of patients developing tolerance 
and addiction to morphine. In this regard they welcomed the use of ketamine as a 
rescue analgesic and they were keen on using the agent as they already had 
experience with the use thereof in the Burns Unit, albeit at much higher doses for 





It would seem that nursing staff chose to comply better with the parts of the protocol 
that was familiar to them i.e. oral analgesics as well as IM morphine. The unfamiliar 
parts of the protocol i.e. documenting pain scores and using ketamine as a rescue 
analgesic showed much less success. It is therefore reasonable to deduct that 
resistance to change is a real challenge. Staff tend to adhere to established habits 
and keep on doing that with which they are most familiar with.49 
 
In an article by Gesme and Wiseman, they make the following statement: “Certain 
elements must be in place in an organization for change to take hold: an agreed-on 
direction for the practice, a functional and effective leadership structure, and a 
culture that promotes and rewards change.”50 Yagasaki says that goal congruence is 
critical at the organizational level. It means that organizational goals are shared by 
all with support of the associated operations and activities.51 This might well be part 
of the challenge at Tygerberg Academic Hospital. 
 
We argue that the main driving force behind a change in analgesia protocol that is 
dependent on nursing interventions, has in fact got to be from nursing side. We 
would suggest that unit managers or shift leaders need to remind staff of the need to 
adhere to the protocol and also to check up on nursing staff to ensure that they do 
actually comply. This would be in line with the teaching of Gesme that says The 
vision for the change has to be communicated effectively to all the parties concerned 
but also needs be reinforced continually. 50  
 
There also needs to be equal partnership between all professionals at 
multidisciplinary level.51  Greater co-operation and understanding between staff from 
different disciplines are needed. There needs to be an understanding of the pressure  
on nursing staff to look after many patients with specific unique needs in a burns 
unit.50 These patients require dressing changes that take a lot of time and often they 
need to be fed if they sustained significant injuries to their hands, this is in addition to 
all the other basic nursing needs in the unit.  
 
It therefore goes without saying that any protocol nurses need to follow has to be 
user friendly and simple to use.51  A probable key to the success in implementing a 




care and satisfaction. By showing individuals how change may help them to do their 
job more effectively could address their fears. 50 
 
Gesme and Wiseman says that the real enemy of change is complacency. Some 
other relevant factors that they describe which may have led to failure of the 
intervention at TAH are: full schedules, distracting events, fear of change and 
apathy. Fear of change may lead to resistance.50 Fear of change and fear of the 
unknown also hinders compliance. Fear freezes the innovation process and lowers 
work productivity according to Serban.52 Guideline implementation is hindered by 
lack of interest in them as well as passive attitudes. 51  
 
The established culture of an organization can also determine the amount of 
resistance to change. Changing the organizational culture is difficult. Culture is 


















6.1 Summary of finding 
 
Compared to the study results of 2012, we were unable to show a statistically 
significant difference in outcome as judged by VAS scores, both for pain at 24 hours 
after surgery and the worst pain experienced in the 1st 24 hours post-operatively. 
Compliance to the new protocol was poor as evidenced by the very low amount of 





The poor compliance to the protocol precludes the investigators from confidently 
concluding that the new protocol is ineffective and without proper clinical application. 
The investigators are still of the opinion that the new protocol potentially holds much 
value and could make a meaningful contribution to patient care. It also has the 
potential to make nursing staff feel empowered to better treat patients in a safe 
guideline based manner without fear of inadvertently causing harm to their patients. 
Even though staff may indicate that they are excited about proposed new strategies 
to address issues that they agree are of concern to them, they still have a reluctance 
to fully embrace changes. Staff members comply much better with procedures that 
they are familiar with.  
 
In order for the effectiveness of the new protocol to be evaluated fairly and to make 
valid conclusions about its clinical use, it would have to be better adhered to. Greater 
involvement from the side of nursing management / unit managers will have to be 
sought. It is neither reasonable nor practical for the anaesthetists who predominantly 
spend their time in the operating theatres to drive the change in units and wards 
where they are not actively involved in the day to day post-surgical management of 
patients once they leave theatre. It is the nursing staff leaders who can best drive the 
adherence to the protocol in the unit and ensure compliance by checking up on their 





6.3 Future Research Recommendations 
 
The goal of the audit was to compare the new analgesia protocol to the previous 
practice, it was focused on the numbers and statistical outcomes. We did however 
identify many areas of concern that would make good future research topics. These 
are listed below. 
 The impact that patients’ preoperative expectations regarding the pain they 
will experience postoperatively have on the eventual pain experienced. 
 Motivation for change of established behaviour and practices in a health care 
setting. 
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DOB Date of birth Patient 
file 
Date 8 DDMMYYYY 
Unknown= 
01011800 






Age Age Date of 
birth 







Sex Gender Patient 
file 
Integer 1 1=Male 
2=Female 
3=Unknown 
1-3 May not 
be 0 
WP Worst pain 




Integer 3 Millimeters 
on VAS 
0-100 May not 
be > 100 





Integer 3 Millimeters 
on VAS 
0-100 May not 






Integer 1 1= yes 
2= no 













































Integer 1 1=yes 
2=no 







Text N/A Description 
of adverse 
event 
N/A Must be 
text 


















Appendix B: Variables 
 
Unique patient identifier number: A numerical value that will be allocated to each 
individual patient by the investigators in order of collecting the data eg. 1st patient 
interviewed will be nr 001, 2nd patient interviewed will be nr 002, etc. 
Date of birth: Collected from the patient file and entered on the CRF in the format of 
DD/MM/CCYY. Will be entered on the Excel spreadsheet in the format of 
DD/MM/CCYY.  
Age: Will be calculated from the CRF by using the Date of birth entered on it, will be 
displayed as years. Rounded down to the lower year eg. 42y 11m will be displayed 
as 42 years. 
Sex: Collected from the patient file and recorded on the CRF. Will be entered on the 
Excel spreadsheet as 1 = Male , 2 = Female, 3 = Unknown. 
Worst pain in 1st 24h: Collected from the CRF after the patient indicated this on the 
appropriate paper VAS. Will be measured by a standard ruler and recorded in 
millimeters for entry on Excel spreadsheet. 
Current pain at time of interview: Collected from the CRF after patient indicated 
this on the appropriate paper VAS. Will be measured by a standard ruler and 
recorded in millimeters for entry on Excel spreadsheet. 
Morphine premed received: Collected from the prescription chart in the patient’s 
file and indicated as yes or no on the CRF. Will be entered on the Excel spreadsheet 
as 1 = yes and 2 = no. 
Morphine doses received post-operatively: Collected from the prescription chart 
in the patient’s file and recorded on the CRF as a numerical value. 
Ketamine doses received post-operatively: Collected from the prescription chart 
in the patient’s file and recorded on the CRF as a numerical value. 
Paracetamol doses received post-operatively: Collected from the prescription 
chart in the patient’s file and recorded on the CRF as a numerical value. 
Tramadol doses received post-operatively: Collected from the prescription chart 
in the patient’s file and recorded on the CRF as a numerical value. 
Amount of pain scores documented on Nursing Observation Chart: Collected 
from the Nursing Observation Chart in the patient’s file and recorded on the CRF as 




Any adverse events: Collected from nursing and doctors’ notes and recorded on 
CRF. Will be entered on the Excel spreadsheet as 1 = yes, 2 = no. 
Describe adverse event: Collected from nursing and doctors’ notes and recorded 












Appendix C: Budget 
 
Item Cost in Rands 
Statistician  600 
Printing costs  400 
Total Cost  1000 
 
Statistician costs to be covered by Department Of Anaesthesiology and Critical Care. 












































































































































































Appendix G: Nursing instruction form 
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